What is the iNO-PF Research Study?

This phase 2b study is investigating whether inhaled nitric oxide (iNO) helps patients who have pulmonary fibrosis and are currently using oxygen therapy. Patients in this study may also be taking medications specific for pulmonary fibrosis.

The INOpulse delivery system will be used to see whether iNO therapy can reduce these patients’ symptoms by decreasing pulmonary pressure and increasing blood flow and oxygenation in the functioning parts of the lungs.

You can learn more about this study at clinicaltrials.gov and search NCT03267108. You may also visit trials.pulmonaryfibrosis.org.

Phase 2b Study

This study is investigating whether iNO improves exercise tolerance by decreasing pulmonary pressure in patients who have pulmonary fibrosis.